17% of PTCL had PD-L1+ tumor cells5% of AITL had PD-L1+ tumor cells27% of CTCL had PD-L1+ tumor cells. This evidence concerns the gene CD274 and mature T-cell and NK-cell non-Hodgkin lymphoma.